MO 10-K Annual Reports

Altria Group, Inc. (MO) has filed an amendment to its 2024 10-K, primarily incorporating financial statements related to its Belgium-based subsidiary, ABI. Investors should note that this filing is an amendment and likely serves to complete the original filing rather than introduce significant new disclosures about Altria's core U.S. operations or financial performance for the year ended December 30, 2024. The incorporation of ABI's financial statements is a key action, suggesting a need for completeness in regulatory reporting. While the specific financial details of ABI are not presented directly in this excerpt, their inclusion implies that this segment may be material or has undergone a reporting change necessitating this amendment. Investors are advised to refer to the full SEC filing, specifically Exhibit 99.3, for the detailed financial statements of ABI and the accompanying auditor's report from PwC Bedrijfsrevisoren BV. The filing also includes standard consent documentation from the auditors, confirming their engagement and agreement with the incorporated information.

Altria Group, Inc. reported robust financial performance for the fiscal year ending December 31, 2024, with reported net earnings of $11.26 billion, a significant increase from $8.13 billion in the prior year. This growth was driven by substantial gains from the sale of the IQOS System commercialization rights, favorable tax items, and positive contributions from equity investments, which largely offset a decrease in operating income. The company's "Moving Beyond Smoking" strategy continues to guide its transition towards smoke-free products. Despite a 10.2% decline in cigarette shipment volume for PM USA and a 1.5% decline in cigar shipments, Altria demonstrated pricing power and cost management, with adjusted diluted EPS increasing by 3.4% year-over-year. The company also advanced its commitment to returning capital to shareholders through substantial share repurchases and a progressive dividend policy. The company faces ongoing challenges including evolving consumer preferences, the proliferation of illicit flavored e-vapor products, and a dynamic regulatory landscape. However, Altria remains focused on its long-term goals, including growing its U.S. smoke-free portfolio and exploring opportunities in new categories. The acquisition of NJOY has been integrated, and while it incurred net pre-tax expenses related to the transaction, it represents a strategic step in expanding Altria's e-vapor offerings. The company's financial position remains solid, supported by substantial cash and cash equivalents and credit facilities, enabling continued investment in its strategic priorities and shareholder returns.

Altria Group, Inc.'s 10-K/A filing on June 4, 2024, for the period ending December 30, 2023, primarily serves as an amendment. The key takeaway for investors from this filing is the incorporation by reference of the ABI Financial Statements and the independent auditor's report from PwC Bedrijfsrevisoren BV. These financial statements, detailed in Exhibit 99.3, provide the audited financial performance for Altria for the fiscal year 2023, reflecting the company's financial health and operational results. While this amendment doesn't introduce significant new operational details or strategic shifts, it formalizes the inclusion of these crucial financial disclosures. Investors should carefully review Exhibit 99.3 for comprehensive financial data, including revenue, profitability, balance sheet information, and cash flows, which are essential for evaluating the company's performance and investment potential. The filing also includes the consent of the independent registered public accounting firm, PwC Bedrijfsrevisoren BV, reinforcing the integrity of the financial reporting.

Altria Group, Inc. (MO) demonstrated resilience in its 2023 performance, navigating a complex operating environment characterized by inflationary pressures and evolving consumer preferences. The company's core smokeable products segment, led by Marlboro, maintained its strong market position, though shipment volumes saw a decline, partly attributed to economic headwinds impacting consumer spending and a shift towards discount brands. To counter this, Altria implemented price increases across its cigarette portfolio, which helped to offset volume declines. The company is actively pursuing its 'Moving Beyond Smoking' strategy, with a significant focus on expanding its smoke-free portfolio. The acquisition of NJOY in June 2023 for approximately $2.9 billion marked a substantial step in strengthening its e-vapor offerings. Altria is also investing in its oral nicotine pouch brand, 'on!', which continues to show robust growth and gain market share within the rapidly expanding oral tobacco category. Despite these growth initiatives, the company faces ongoing regulatory scrutiny and competition, particularly from illicit e-vapor products, which continue to impact the broader market dynamics.

Altria Group, Inc. (MO) filed an amendment to its 2022 10-K on May 31, 2023, primarily to incorporate financial statements and auditor reports for its Belgian subsidiary, ABI. This filing does not appear to introduce significant new operational or financial information regarding the parent company for the 2022 fiscal year beyond what was likely presented in the original 10-K. Investors should note that the core financial performance and strategic direction for Altria remain detailed in the original 10-K filing, with this amendment serving a specific administrative purpose related to its international operations. For investors, the key takeaway is to refer to the original 10-K for a comprehensive understanding of Altria's 2022 performance, including its tobacco segments (Marlboro, Black & Mild), and its investments in reduced-risk products and other ventures. The amendment's focus on ABI suggests a need for compliance and transparency regarding its European financial reporting, rather than a material shift in Altria's overall financial health or strategic outlook.

Altria Group, Inc. reported solid financial performance in 2022, with reported net earnings attributable to Altria of $5.8 billion, up from $2.5 billion in 2021. Adjusted net earnings attributable to Altria increased by 2.6% to $8.7 billion, and adjusted diluted EPS grew by 5.0% to $4.84. This growth was driven by higher operating income in the smokeable products segment and improved pricing, partially offset by ongoing shifts in adult tobacco consumer preferences and macroeconomic pressures. The company continues its "Moving Beyond SmokingTM" strategy, aiming to transition adult smokers to smoke-free products by 2030, underscored by its investments in smoke-free innovation and partnerships. Despite a decline in cigarette shipment volumes, Altria managed to offset this through effective pricing strategies and cost management. The oral tobacco products segment experienced a slight net revenue decrease, impacted by lower shipment volumes, though the "on!" oral nicotine pouch brand showed significant growth within its category. The company also highlighted significant non-cash charges related to its equity investments, particularly a $2.5 billion impairment charge for its investment in Anheuser-Busch InBev (ABI) and unrealized losses of $1.5 billion for its investment in JUUL. Altria remains committed to returning value to shareholders through dividends and share repurchases, with a new $1 billion share repurchase program authorized.

Altria Group, Inc.'s 10-K/A filing from May 31, 2022, primarily serves as an amendment to its previously filed annual report for the period ending December 30, 2021. This specific amendment references the incorporation of ABI Financial Statements and the auditor's report from PwC Bedrijfsrevisoren BV, located in Belgium, within Exhibit 99.3. This suggests that the core financial reporting and auditor's opinion for the period are contained within this referenced exhibit, rather than being fully detailed within this amendment itself. Investors should pay close attention to Exhibit 99.3 for a comprehensive understanding of Altria's 2021 financial performance and the independent audit findings. The filing also includes Exhibit 23.1, a consent from the independent registered public accounting firm, PwC Bedrijfsrevisoren BV. This consent is a standard component of SEC filings, confirming the firm's approval for its report to be included in the filing. While this amendment doesn't introduce new material financial data directly, it ensures the completeness and proper referencing of audited financial statements and auditor opinions for the 2021 fiscal year.

Altria Group, Inc.'s 2021 10-K filing highlights a year of strategic divestitures, including the sale of its wine business, Ste. Michelle Wine Estates, for approximately $1.2 billion. The company continues its 'Moving Beyond Smoking' vision, focusing on transitioning adult smokers to smoke-free alternatives. Despite a reported net loss attributable to Altria of $2.5 billion for 2021, primarily due to significant special items including a substantial impairment charge related to its investment in ABI ($6.2 billion), the adjusted net earnings and adjusted diluted earnings per share showed year-over-year growth, reflecting the underlying operational performance. The company faced challenges in its innovative tobacco products segment, particularly with the IQOS heated tobacco system, which was removed from the market due to an ITC exclusion order, with no expected access in 2022. However, the core smokeable products segment demonstrated resilience with increased operating income, driven by pricing actions that offset shipment volume declines. The oral tobacco products segment also saw modest revenue growth. Altria remains committed to its dividend payout ratio target of approximately 80% of adjusted diluted EPS and announced a $3.5 billion share repurchase program.

Altria Group, Inc.'s 2020 10-K filing, amended and filed on May 25, 2021, details the company's financial performance and strategic positioning. While the provided excerpt is limited to the exhibits section, it indicates a comprehensive review of financial statements, including those from ABI (likely a subsidiary or related entity) incorporated by reference. Investors should note that this amendment likely addresses specific disclosures or reclassifications, and the full 10-K report (not fully provided here) would contain crucial details on revenue, profitability, debt, and strategic initiatives. The presence of multiple independent registered public accounting firm consents suggests a thorough audit process and potential complexities in financial reporting across different business segments or acquisitions.

Altria Group, Inc.'s (MO) 2020 Form 10-K reveals a company navigating a transitional period, with a stated vision to "responsibly lead the transition of adult smokers to a non-combustible future." While the core business remains dominated by smokeable products, particularly Marlboro cigarettes, which showed stable shipment volumes despite a slight decline, the company is actively investing in and growing its oral tobacco product segment, with 'on!' oral nicotine pouches showing notable volume increases. The company's financial performance in 2020 was significantly impacted by a substantial impairment charge related to its investment in JUUL, amounting to $2.6 billion, following an $8.6 billion charge in 2019. This, along with other special items like those related to investments in ABI and Cronos, contributed to a year-over-year increase in reported net earnings. Altria continues its commitment to shareholder returns through dividends and share repurchases, announcing a new $2.0 billion repurchase program in January 2021. However, the company faces ongoing risks from litigation, evolving regulatory landscapes (particularly from the FDA), excise taxes, and shifts in consumer preferences, all of which are critical factors for investors to consider.

Altria Group, Inc.'s 2019 10-K filing, amended and filed on May 18, 2020, provides a look into the company's performance and strategic direction. While the provided excerpt focuses on the exhibit list and financial statement references, it indicates that the core financial statements, including those for ABI (likely a subsidiary or related entity), are incorporated by reference. Investors should note that a full review of the 10-K, especially the consolidated financial statements and Management's Discussion and Analysis, is crucial for a comprehensive understanding of Altria's financial health, operational performance, and future outlook, particularly given the dynamic regulatory and market environment for tobacco and related products.

Altria Group, Inc. reported a net loss of $1.3 billion for the year ended December 31, 2019, a significant shift from the $7.0 billion net earnings in the prior year. This decline was largely driven by an $8.6 billion impairment charge related to its investment in JUUL, coupled with a $1.4 billion loss on Cronos-related financial instruments. Excluding these and other special items, Altria's adjusted diluted earnings per share were $4.22, demonstrating underlying operational performance. The company forecasts 4%-7% adjusted diluted EPS growth for 2020, indicating confidence in its core business despite the significant investment write-downs. The company's primary revenue driver, the smokeable products segment (cigarettes and cigars), saw a slight decrease in net revenues, primarily due to lower shipment volumes, although pricing actions helped offset some of this decline. The smokeless products segment showed modest net revenue growth, supported by higher pricing. However, the wine segment experienced a decline in operating income, partly due to a goodwill impairment charge. Altria's strategic investments in JUUL and Cronos have significantly impacted profitability in 2019, highlighting the risks associated with diversifying into new product categories.

Altria Group, Inc. (MO) filed an amendment to its 2018 10-K on May 28, 2019, primarily concerning the incorporation by reference of AB InBev Financial Statements. While this filing doesn't present new financial data for Altria itself, it signals significant ongoing involvement and financial connections with Anheuser-Busch InBev. Investors should note that this amendment focuses on exhibit disclosures and does not alter the core financial performance or strategic outlook presented in the original 10-K. The AB InBev financial information incorporated by reference is crucial for understanding the consolidated financial position and performance where Altria's investment in AB InBev is a material component.

Altria Group, Inc. reported net revenues of $25.36 billion for the year ended December 31, 2018, a slight decrease from the prior year, primarily driven by lower net revenues in the smokeable products segment, partially offset by higher net revenues in the smokeless products segment. The company's net earnings attributable to Altria decreased significantly to $6.96 billion from $10.22 billion in the prior year, largely due to a higher effective income tax rate resulting from the Tax Reform Act, lower operating income, and a large gain on the AB InBev transaction in the prior year. The company made significant strategic investments in 2018, notably a $12.8 billion investment in JUUL Labs, Inc., representing a 35% economic interest, and announced an agreement to acquire a 45% equity interest in Cronos Group Inc., a cannabinoid company. Despite the overall revenue dip, Altria demonstrated pricing power across its segments, with higher pricing helping to offset lower shipment volumes. The company also announced a cost reduction program expected to yield $575 million in annualized savings by the end of 2019. The report highlights ongoing challenges, including declining cigarette volumes, regulatory scrutiny from the FDA, and litigation risks. However, strategic investments in newer product categories like e-vapor and cannabis signal a forward-looking approach to adapt to evolving consumer preferences and market trends.

Altria Group, Inc.'s 2017 10-K filing, though an amendment, provides insights into its financial performance and strategic positioning, primarily centered around its core tobacco businesses. The company continues to navigate a challenging but resilient market, characterized by declining cigarette volumes but offset by pricing power and diversification efforts. Investors should note Altria's ongoing commitment to returning capital to shareholders through dividends, a long-standing strategy that remains a key component of its investment thesis. The filing also touches upon regulatory risks and the company's efforts to adapt to evolving consumer preferences and industry trends, including investments in reduced-risk products.

Altria Group, Inc. reported total net revenues of $25.576 billion for the year ended December 31, 2017. The company's primary segments are smokeable products, smokeless products, and wine. The smokeable products segment, driven by Marlboro, continues to be the largest contributor to operating companies income, despite a slight decline in cigarette shipment volume. The smokeless products segment, featuring Copenhagen and Skoal, demonstrated growth in net revenues and operating companies income, partly due to price increases. The wine segment, primarily Ste. Michelle Wine Estates, experienced a decline in net revenues and operating companies income, attributed to competitive pressures and inventory adjustments. Financially, Altria demonstrated strong operating cash flow and maintained a solid credit rating. The company completed a $4.0 billion share repurchase program in early 2018 and authorized a new $1.0 billion program. Dividends paid to shareholders increased by 6.5% in 2017, reflecting the company's commitment to returning capital to investors. A significant event impacting net earnings was the enactment of the Tax Cuts and Jobs Act, which resulted in a substantial tax benefit in 2017. The company faces ongoing regulatory scrutiny and litigation risks inherent in the tobacco industry, but continues to navigate these challenges while focusing on innovation and strategic brand management.

Altria Group, Inc. (MO) filed its 2016 Annual Report Amendment on June 14, 2017. This filing primarily serves to incorporate by reference the AB InBev Financial Statements (Exhibit 99.4) and includes consents from various independent registered public accounting firms, indicating necessary audit disclosures and regulatory compliance. While the excerpt doesn't detail operational performance or strategic initiatives, investors should note the inclusion of AB InBev's financials, suggesting a significant relationship or investment that impacts Altria's reporting. The consents from multiple auditing firms highlight the complexity of Altria's financial structure and its adherence to auditing standards across its various entities or investments. Investors should interpret this amendment as a procedural update confirming the integration of specific financial data and the satisfaction of auditing requirements. For a comprehensive understanding of Altria's 2016 performance, profitability, and future outlook, a review of the full 10-K filing, including the incorporated AB InBev financial statements and the company's Management's Discussion and Analysis of Financial Condition and Results of Operations, is essential. This particular excerpt focuses on the administrative and compliance aspects of the filing rather than direct financial performance metrics.

Altria Group, Inc. (MO) reported strong financial performance for the fiscal year ended December 31, 2016, primarily driven by a significant one-time gain from the AB InBev/SABMiller business combination. This transaction resulted in a substantial increase in net earnings and diluted EPS for the year. The core tobacco businesses, smokeable and smokeless products, demonstrated resilience with positive operating income growth, supported by higher pricing and, in the case of smokeless products, increased shipment volumes. The company continued its commitment to shareholder returns through robust dividend payments and share repurchases, reflecting confidence in its ongoing operational performance and cash flow generation. Despite the positive overall results, Altria continues to navigate a complex operating environment characterized by ongoing litigation, regulatory scrutiny, and evolving consumer preferences in the tobacco industry. The company is actively managing these challenges through strategic pricing, cost efficiencies, and investments in innovative tobacco products. The significant gain from the AB InBev investment provided a substantial boost to earnings, but underlying operational performance in the tobacco segments remains critical for long-term value creation.

Altria Group, Inc.'s 2015 10-K filing indicates a solid financial performance with growth driven by its core smokeable and smokeless product segments. The company reported an increase in net revenues and operating income compared to the previous year. Key drivers included pricing strategies and market share gains in its premium cigarette brands, particularly Marlboro, and continued strength in its smokeless tobacco portfolio with brands like Copenhagen and Skoal. While the company continues to navigate a challenging regulatory environment and litigation landscape, it demonstrates a commitment to shareholder returns through consistent dividend payments and share repurchases. The company also highlights its strategic investments in innovative tobacco products, signaling a forward-looking approach to adapting to evolving consumer preferences. The significant equity investment in SABMiller remains a notable asset, though its earnings contribution saw a decrease in 2015. Investors should note the ongoing litigation risks, particularly concerning tobacco-related lawsuits, and the impact of federal regulations on the tobacco industry. However, the company's diversified product portfolio and strong brand equity in its core segments provide a foundation for continued financial stability.

This filing is an amendment to Altria Group, Inc.'s 2014 Annual Report (10-K), specifically addressing Item 15. The primary purpose of this amendment is to include the consolidated financial statements of its significant foreign equity investee, SABMiller plc, as required by SEC Regulation S-X Rule 3-09. These statements cover the years ended March 31, 2015, 2014, and 2013. Investors should note that this amendment does not update Altria's core financial performance or disclosures from the original 10-K filed on February 25, 2015, nor does it reflect events occurring after that date. Its focus is purely on the supplemental financial information related to SABMiller.

Altria Group, Inc. reported strong financial performance for the fiscal year ended December 31, 2014, with net earnings attributable to Altria Group, Inc. of $5.07 billion, a 11.8% increase from the prior year, driven by lower losses on debt extinguishment and reduced interest expenses. The company's primary revenue driver remains its smokeable products segment, which includes the flagship Marlboro brand, though shipment volumes for cigarettes saw a slight decline. The smokeless products segment, led by Copenhagen and Skoal, demonstrated growth in both shipment volume and retail share. The innovative tobacco products segment, notably the MarkTen e-vapor products, saw expanded national distribution. The company continued its commitment to shareholder returns through significant dividend payments and share repurchases, with over $939 million spent on repurchases during the year.

This 10-K filing for Altria Group, Inc. (MO) covers the fiscal year ending December 30, 2013, and was amended and filed on August 3, 2014. The filing primarily consists of amendments to previously submitted information and the incorporation by reference of SABMiller Financial Statements. While the specific details of the operational performance and financial results for Altria are not explicitly detailed within this amendment itself (as it focuses on exhibits), investors should note that this filing incorporates by reference significant financial data from SABMiller, suggesting a strategic relationship or investment interest in that entity. Investors should refer to the primary 10-K filing for the detailed financial performance and management's discussion and analysis of Altria's core business operations, including its tobacco segments.

Altria Group, Inc. reported solid financial performance for the fiscal year ending December 31, 2013, with net earnings of $4.535 billion, an increase of 8.5% compared to the previous year. Diluted EPS also saw a significant increase of 9.7% to $2.26. This growth was driven by higher operating income from its core smokeable and smokeless products segments, lower interest expenses, and a lower effective income tax rate. The company continued its disciplined approach to capital allocation, repurchasing shares under its authorized program and increasing its dividend payout. Despite the positive financial results, Altria Group faces ongoing challenges inherent in the tobacco industry, including regulatory scrutiny from the FDA under the FSPTCA, significant excise taxes, and the persistent threat of litigation. The company is actively engaged in developing "innovative tobacco products," notably expanding its e-vapor offerings with the planned acquisition of Green Smoke, Inc. While these new product categories represent future growth potential, the core cigarette business remains the primary revenue and profit driver.

Altria Group, Inc. filed an amendment to its 2012 10-K on August 13, 2013, primarily to incorporate financial statements of SABMiller, in which Altria holds a significant stake. Investors should note that this filing is an amendment and not the original 10-K. The core business of Altria remains focused on tobacco products, including cigarettes, smokeless tobacco, and cigars, with its primary operating segments being U.S. Smokeless Tobacco Company, John Middleton Co., and Ste. Michelle Wine Estates. The incorporation of SABMiller's financials suggests a material impact or interest from this investment on Altria's consolidated results, though the specific details of this impact would be found within the referenced exhibits.

In the fiscal year ending December 31, 2012, Altria Group, Inc. (MO) demonstrated resilience and growth, with net earnings attributable to Altria Group, Inc. increasing by 23.3% to $4.18 billion compared to the prior year. This growth was driven by strong performance across its key segments, particularly smokeable and smokeless products, supported by effective pricing strategies and cost management. The company also benefited from higher equity earnings from its significant investment in SABMiller plc. Despite facing ongoing regulatory and litigation challenges inherent in the tobacco industry, Altria managed its operations effectively, reflected in a 25.6% increase in diluted Earnings Per Share (EPS) to $2.06. Altria continued to return value to shareholders through a 7.3% increase in its quarterly dividend to $0.44 per share and substantial share repurchases totaling $1.1 billion under its $1.5 billion repurchase program. The company maintained a stable credit rating, with a positive outlook from major credit rating agencies, underscoring its financial stability. Looking ahead, Altria provided a cautious but optimistic forecast for 2013, expecting reported diluted EPS growth of 6% to 9%, reflecting confidence in its ongoing business strategies and ability to navigate the evolving market landscape.

Altria Group, Inc.'s 2011 Form 10-K highlights a company focused on its core tobacco products, primarily cigarettes (Philip Morris USA) and smokeless products (U.S. Smokeless Tobacco Company), while also maintaining interests in wine (Ste. Michelle Wine Estates) and financial services (Philip Morris Capital Corporation). The company reported a decrease in cigarette shipment volume but maintained market leadership with its Marlboro brand. The smokeless products segment saw a slight increase in volume. Altria's financial services segment, PMCC, continued to manage its existing portfolio of finance leases. A significant portion of the filing details ongoing legal proceedings, particularly tobacco-related litigation, including smoking and health cases, health care cost recovery actions, and "Lights/Ultra Lights" cases. The company has achieved substantial success in managing litigation but acknowledges the inherent uncertainties and the potential for material impact on financial results. Regulatory environments, including FDA oversight under the Family Smoking Prevention and Tobacco Control Act, and excise taxes continue to be key factors influencing the tobacco industry. Altria also addressed a significant charge related to PMCC's leveraged lease transactions and ongoing tax matters with the IRS.

Altria Group, Inc. (MO) reported its 2010 fiscal year results in this 10-K filing. The company, a holding company with subsidiaries in tobacco (cigarettes, smokeless products, cigars), wine, and financial services, saw a continued decrease in cigarette shipment volumes, though its premium Marlboro brand maintained its leading market share. The acquisition of UST in 2009 significantly contributed to the growth of its smokeless products segment, which showed increased shipment volumes and market share. Financial performance was impacted by ongoing litigation, particularly tobacco-related lawsuits, which represent a significant ongoing risk. The company also highlighted its commitment to shareholder returns through dividend increases and a new share repurchase program authorized in early 2011. Regulatory scrutiny, especially from the FDA regarding tobacco products, remains a key factor influencing the business environment and future strategies. Investors should note the company's strategic focus on its core tobacco and wine businesses, managing litigation risks, and maintaining its dividend policy.

Altria Group, Inc.'s 2009 Form 10-K highlights a year marked by significant strategic acquisitions and ongoing challenges within the tobacco industry. The company completed the acquisition of UST LLC for approximately $11.7 billion, integrating its smokeless tobacco and wine businesses, which significantly diversified Altria's revenue streams and contributed to the newly formed smokeless products and wine segments. Despite a decline in cigarette shipment volumes, the core Marlboro brand maintained its leading market share in the U.S. premium cigarette segment. Altria also experienced a shift in its business segments' profitability contribution, with cigarettes decreasing and smokeless products and wine gaining importance. The company continued its commitment to shareholder returns by increasing its quarterly dividend. However, Altria faces persistent risks from ongoing tobacco-related litigation, increasing excise taxes, and evolving regulatory landscapes, including the new Family Smoking Prevention and Tobacco Control Act granting the FDA broad regulatory authority over tobacco products.

Altria Group, Inc. (MO) filed its 2008 10-K report on February 26, 2009, detailing its business operations and financial condition as of December 31, 2008. A significant event discussed is the acquisition of UST Inc. on January 6, 2009, for approximately $11.7 billion. This strategic move significantly expands Altria's footprint in the smokeless tobacco market, complementing its existing strong position in cigarettes and cigars. The report highlights the company's core tobacco businesses, primarily through Philip Morris USA (PM USA) for cigarettes and John Middleton Co. (Middleton) for cigars. PM USA continues to dominate the U.S. cigarette market with its flagship Marlboro brand. Despite an overall slight decline in cigarette shipments, the company maintained its market share. The company also continued its dividend payouts and share repurchases, although a significant share repurchase program was suspended in January 2009 to preserve financial flexibility amidst economic uncertainty. Investors should note the ongoing risks associated with tobacco litigation and increasing excise taxes, which remain material factors for the company's operating environment.

Altria Group, Inc. (MO) in its 2008 10-K filing primarily details its business operations and the significant upcoming spin-off of its international tobacco segment, Philip Morris International Inc. (PMI). This spin-off, scheduled for March 28, 2008, will result in Altria shareholders receiving one share of PMI for each Altria share owned. Following the distribution, Altria's annualized dividend is expected to be $1.16 per share, and PMI's will be $1.84 per share, with both companies establishing dividend policies with target payout ratios. The company also highlights its recent acquisition of John Middleton, Inc., a major manufacturer of machine-made large cigars, for $2.9 billion. This acquisition is part of Altria's strategy to diversify its product offerings. The filing also reiterates the prior spin-off of Kraft Foods Inc. in 2007 and details the ongoing legal proceedings, particularly those related to tobacco litigation, which remain a significant factor for the company. Investors should note the strategic shift away from international operations with the PMI spin-off and the continued focus on the U.S. tobacco market and cigar segment.

Altria Group, Inc. (MO) is presenting its 2006 annual report, highlighting significant developments and the company's operational segments. A key event is the announced plan to spin off its 89% interest in Kraft Foods Inc. on March 30, 2007, a move intended to be tax-free for shareholders. This strategic decision will lead to Altria focusing primarily on its tobacco businesses: Philip Morris USA (PM USA) and Philip Morris International (PMI). The company operates through distinct segments: domestic tobacco, international tobacco, North American food, international food, and financial services. International tobacco remains the largest contributor to operating income, followed by domestic tobacco and then food businesses. The financial services segment, primarily PMCC, is undergoing a strategic shift towards maximizing returns from its existing lease portfolio rather than pursuing new investments. Investors should note the ongoing legal challenges, particularly tobacco-related litigation, which, while historically managed, represents a significant risk factor.

Altria Group, Inc. (MO) in its 2005 10-K filing presents a diversified business structure with its core tobacco operations, both domestic (PM USA) and international (PMI), alongside its significant holding in Kraft Foods Inc. The company is exploring strategic restructuring options, including potential separation into multiple entities, contingent on improvements in the litigation environment. Revenue generation remains heavily reliant on tobacco, with Marlboro as a globally dominant brand. Significant investments in international markets, notably the acquisition of PT HM Sampoerna Tbk in Indonesia, highlight strategic expansion efforts. Kraft Foods Inc., while a substantial part of the portfolio, is undergoing significant restructuring, including divestitures and workforce reductions, impacting its short-term financial performance but aimed at long-term efficiency. The financial services segment, PMCC, faces challenges with its leasing portfolio, particularly due to airline industry bankruptcies, leading to provisions for losses and impacting liquidity. Investors should note the ongoing legal risks, primarily related to tobacco litigation, which remain a significant factor influencing the company's strategic decisions and financial outlook.

Altria Group, Inc. (MO) in its March 15, 2005, 10-K filing for the fiscal year ended December 30, 2004, presents a diversified business portfolio dominated by its tobacco operations (Philip Morris USA and Philip Morris International), alongside a significant stake in Kraft Foods Inc. The company highlights its strong market positions, with Marlboro remaining the world's largest-selling cigarette brand. Key strategic considerations include ongoing litigation related to tobacco products, which continues to be a material factor influencing financial results and operational flexibility. Furthermore, Altria is exploring strategic alternatives, including potential separation into distinct entities, contingent on improvements in the litigation environment. The Kraft Foods segment is undergoing a significant restructuring, including divestitures and cost-saving initiatives. The financial services segment, PMCC, is facing challenges related to airline industry exposure. Investors should note the company's primary funding source is dividends from its subsidiaries and the substantial legal risks associated with its tobacco business.

Altria Group, Inc. (MO) reported its 2003 fiscal year results in this 10-K filing, highlighting a diversified consumer products business with significant operations in tobacco (Philip Morris USA and Philip Morris International) and food (Kraft Foods Inc.). The company faced ongoing challenges in the tobacco segment, including declining domestic volumes, intense price competition, and significant litigation risks. Despite these headwinds, the company emphasized its leading market positions and strategies to mitigate volume declines. The food segment, through Kraft, continued to be a substantial contributor, with ongoing restructuring efforts aimed at improving efficiency and cost structure. Financial performance in 2003 was influenced by these segment dynamics. The tobacco business saw its relative contribution to operating companies income decrease, while the food segment's contribution remained stable or slightly increased. The company also highlighted its financial services segment (PMCC), which was shifting its strategy to maximize gains from its existing portfolio. Investors should note the significant legal proceedings, particularly tobacco litigation, and the potential financial impact of unfavorable outcomes. The company's strategy involved leveraging its scale, brand strength, and operational efficiencies to navigate a complex and evolving regulatory and competitive landscape.

Altria Group, Inc.'s 2002 Form 10-K reveals a company undergoing significant structural changes and facing substantial legal and regulatory challenges, primarily within its tobacco segment. The company officially changed its name from Philip Morris Companies Inc. to Altria Group, Inc. in January 2003, reflecting its broader portfolio. A major event was the merger of its Miller Brewing Company subsidiary into South African Breweries plc (SAB), resulting in a significant pre-tax gain and a retained stake in the new entity, SABMiller plc. The core domestic tobacco business, Philip Morris USA (PM USA), experienced a decline in shipment volume and market share, attributed to increased excise taxes, weak economic conditions, and intense price competition, particularly from deep-discount brands. Despite these challenges, the international tobacco business (PMI) showed growth in shipments and market share, driven by the iconic Marlboro brand. Kraft Foods, Altria's significant food and beverage subsidiary, continued its integration of the Nabisco acquisition, realizing cost synergies and pursuing strategic acquisitions and divestitures. However, the company's financial services segment, particularly its aircraft leasing portfolio, was impacted by airline industry bankruptcies, necessitating a substantial allowance for losses. Investors should be aware of the significant ongoing tobacco-related litigation, including substantial jury verdicts, and the ever-present regulatory and legislative risks that could materially affect future results.

Altria Group, Inc. (MO) filed its 1998 10-K annual report on March 18, 1999, detailing its financial performance and business operations for the fiscal year ending December 30, 1998. As a major player in the tobacco industry, the report would have provided investors with critical insights into revenue streams, profitability, and any associated risks or strategic initiatives undertaken by the company during that period. Investors would scrutinize this filing for trends in cigarette consumption, pricing strategies, and any developments related to litigation or regulatory challenges, which are historically significant factors for tobacco companies. While the provided text is a directory listing from the SEC's EDGAR database and does not contain the full financial statements or management's discussion and analysis, it indicates the availability of the 10-K filing. Investors would typically look for information on net sales, operating income, net earnings, earnings per share, and the company's balance sheet. Furthermore, disclosures regarding segment performance (e.g., U.S. Smokable Products, U.S. Oral Tobacco, International Cigarette Operations) and any forward-looking statements or risk factors would be of paramount importance for assessing the company's future prospects and valuation.

This 10-K filing from Altria Group, Inc. for the period ending December 30, 1995, provides a snapshot of the company's financial and operational status in the mid-1990s. As a major player in the tobacco industry, investors would be interested in the company's performance and any disclosed risks. The filing would typically detail revenues, profits, assets, liabilities, and significant business segments, offering insights into the company's competitive positioning and growth prospects. Investors should pay close attention to any discussions regarding litigation, regulatory changes, or evolving market trends that could impact the tobacco industry and, by extension, Altria's profitability and stock valuation. The historical context of this filing is crucial for understanding the challenges and opportunities faced by the company at that time, including evolving public health concerns and potential legal battles.

This 10-K filing from Altria Group, Inc. (MO) for the period ending December 30, 1994, represents a snapshot of the company's financial health and operational status as reported in early 1995. While the provided text is a directory listing and not the full financial report, it indicates that Altria was actively filing its annual disclosures. Investors in 1995 would have looked to this filing for crucial details on revenue streams, profitability, debt levels, and any significant business developments or risk factors. The company's performance in the preceding fiscal year would have been assessed, along with management's outlook and any forward-looking statements. Given the historical context of 1995, key areas of interest would have included the performance of its tobacco segments, any diversification efforts, and its market share within the industry. Regulatory and legal environments surrounding tobacco products were also evolving, and investors would have scrutinized the filing for any discussions on potential impacts. Understanding the company's capital structure and its ability to generate cash flow would have been paramount for evaluating its investment potential.

This 10-K filing for Altria Group, Inc. (MO) for the fiscal year ending December 30, 1993, represents a significant historical document for investors. As the filing is from 1994, it provides insights into the company's performance and strategic positioning prior to major market shifts and regulatory changes that would impact the tobacco industry in subsequent years. Investors reviewing this filing should pay close attention to the disclosed financial statements, management's discussion and analysis of financial condition and results of operations, and any risk factors identified at that time. Given the nature of the tobacco industry, investors should specifically look for details regarding sales volumes, pricing strategies, geographic diversification, and any pending or potential litigation. The company's capital allocation, including dividends, share repurchases, and investments, will also be crucial for understanding its commitment to shareholder returns during this period. Understanding the business environment and regulatory landscape of 1993 is key to interpreting the financial data presented in this report.